Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
Trends and Finance
Patients prefer immediate test results, even when the news is bad
In a recent survey, patients overwhelmingly preferred receiving their test results immediately, even if their provider had not yet reviewed them.
Featured
COVID-19
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Payor Coverage
For 2016 and 2017, Geisinger received at least $6.5M in overpayments from CMS: HHS OIG report
Latest News
Contagious fungal infections increase dramatically
March 21, 2023
Guardant Health, Ohio State University study colorectal cancer screening adherence
March 21, 2023
Invitae partners with Epic on workflow for genetic testing results
March 21, 2023
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
March 21, 2023
Business Insights
Financial Results
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Regulatory Approval
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
FDA Clearance
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
Mergers & Acquisitions
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Diagnostic Technologies
Rare Disease
Genetic causes identified for three rare diseases
Hepatitis
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
Mass Spec
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
Technology Development
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Diseases
Emergency Use Authorization
Cue Health receives FDA emergency use authorization for molecular mpox test
510(k)
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
COVID-19
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Rare Disease
Genetic causes identified for three rare diseases
More from LabPulse.com
Cue Health receives FDA emergency use authorization for molecular mpox test
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Gestational diabetes rise linked to screening practices
Although gestational diabetes is reportedly on the rise, a study finds that changes in screening practices may explain much of the increase.
March 20, 2023
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
The Santa Clara, CA-based company said it will use the funds to complete the development and commercialization of the Proxim Profile System, a portable and fully automated immunodiagnostic device.
March 21, 2023
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
The test detects and differentiates influenza A, influenza B, and SARS-CoV-2 viruses to help ensure physicians can recommend the most appropriate treatment for each patient.
March 20, 2023
Genetic causes identified for three rare diseases
A computational approach helped identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
March 16, 2023
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.
March 20, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
More from LabPulse.com
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
Clinical investigators need to look out for confounding and bias associated with real-world data in randomized trials and observational studies used to produce real-world evidence (RWE) to assess the safety and efficacy of an intervention.
March 17, 2023
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
The company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.
March 16, 2023
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
The test provides early detection for infants with homocystinuria, an inherited disease that causes serious complications if left untreated.
March 16, 2023
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Molecular test in study identified hypnotizable patients for postoperative pain treatment
A molecular point-of-care test identified individuals for whom hypnosis may relieve postoperative pain, potentially reducing opioid use.
March 15, 2023
